Objectives: In multicenter urodynamic studies (UDS) there can be considerable variations in testing procedures, training, equipment, and reviewer biases. The purpose of this paper is to describe our experiences with a continuous quality improvement process for the standardization of multicenter UDS in a multi-institutional network.
Introduction
The reliability and reproducibility of urodynamic data depends on standardized technical performance, annotation, and interpretation 1 . International Continence Society (ICS)
subcommittees have issued reports on the standardization of urodynamic terminology, terminology relating to lower urinary tract dysfunction, and Good Urodynamic Practice (GUP) guidelines 2 , however these reports do not focus on how to implement and assess compliance of both technique and interpretation in a multi-center environment. In large multicenter studies there can be considerable variations in testing procedures, training, equipment, and reviewer biases. In a multicenter study of benign prostatic hypertrophy, Schaefer et al. demonstrated that many urodynamic tracings could not be interpreted 3 . Previous investigators involved in other multicenter studies have argued for a standard urodynamic protocol and central review of urodynamic data to provide a single standard of interpretation 4 . Pressure flow studies (PFS) in multicenter investigations have been particularly difficult to interpret; up to 38% of the tracings in the multi-center ICS BPH study were rejected during a central review 5 . One multicenter study on men with BPH eventually demonstrated adequate agreement between the investigator and a quality control center when a consensus protocol was developed, but this protocol included insertion of a suprapubic catheter under local anesthesia 6 . There are no other standardization models or quality control publications on multicenter urodynamic studies (UDS) in women.
The Urinary Incontinence Treatment Network (UITN) is a consortium of investigators from 9
continence treatment centers (centers) with support from a biostatistical coordinating center The UITN Steering Committee -recognizing some of the potential problems that others had encountered with multicenter UDS -established a Urodynamic Studies Work Group (UDS WG) composed of two urologists and two urogynecologists to develop a standardized UDS protocol and maximize consistency and quality in the performance of urodynamic testing across study centers. The purpose of this paper is to describe the process involved with the development of a multi-center UDS protocol, the difficulties we encountered during that process, and the quality control efforts that were necessary in order to obtain reliable and interpretable UDS data from each of the centers.
Materials and Methods
The on-going quality control process occurred before the start of the surgical study and during early data acquisition and included:
• UDS protocol development, certification of testers and resolution of site-specific differences in UDS methods;
• Initial central review to assess compliance with protocol and quality of UDS.
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• Protocol modifications, UDS conference calls, and regular assessment of protocol compliance;
• Standardization of UDS equipment, signal configuration, and the development of an electronic signal repository;
• Assessments of the reliability of UDS interpretation between local and central reviewers
• Development of UDS Interpretation Guidelines

Results
UDS Protocol development, certification of testers and resolution of site-specific differences in UDS methods
The UDS WG met at least monthly during the year prior to study implementation, developing and refining standardization for urodynamic testing procedures. The SISTEr UDS protocol complied with terminology from the Standardization Committee of the ICS 2 and technical suggestions from the Good Urodynamic Practice guidelines 7 . Several study-specific urodynamic details that were not explicitly described in the ICS Standardization Committee documents were defined by Steering Committee consensus. These included:
1. Filling cystometry performed in the standing position. Voiding would be in the sitting position.
2. The filling cystometry infusion rate would be 50 ml per minute.
3. ICS definitions for bladder sensation parameters would be translated to lay language. A scripted prompt using a television watching scenario was developed and used by testers at all centers. Prolapse reduction would be performed with a sponge stick or gauze pack.
6. Urethral relaxation during voiding pressure flow studies (PFS) would be assessed by perineal surface electromyography (EMG) patches.
All UDS testers were required to be certified on UDS protocol performance by the principal investigators at their center before beginning the study.
Initial central review to assess compliance with protocol and quality of UDS
The UDS WG reviewed the first 11 studies performed under the UDS protocol. This review identified several significant problems including poor protocol adherence, poor tracing quality and lack of annotations. Telephone conference calls with the UDS testers were initiated as a means to answer technical and procedural questions and emphasize protocol adherence and standard annotations. Investigators, rather than data entry personnel, were required to fill out the data forms to cut down on transcription errors. Follow-up assessment included a central review of the first three signals from each UDS tester with a written feedback program to each tester. Standing UDS WG reports, including a "Top Ten Reminders" list, were developed to review with investigators at each monthly Steering Committee meeting.
These initial reviews highlighted specific aspects of the protocol that proved difficult to standardize among the 20 testers. This electronic signal repository allowed urodynamic signals to be forwarded electronically to central reviewers throughout the United States for frequent quality control assessments.
Preliminary evaluation of interpretation reliability assessments
The next stage of quality control was a systematic evaluation of the reliability of urodynamic interpretation across UITN physician reviewers. Interrater reliability between central reviewer and the local reviewers was assessed with a blinded re-interpretation of 24 signals originally reviewed by local UITN Physician Investigators. We defined "Agreement" if all 3 central reviewers recorded the same integer value or reached the same conclusion as the original local reviewer. In general, agreement was higher for quantitative than for qualitative measures. This early assessment of the UDS data indicated that there were significant issues that needed to be resolved. The inter-rater reliability for PFS was most problematic, as reviewers had widely differing views on when a particular voiding study could be considered plausible and interpretable. Investigators used different criteria for deciding how and when artifacts could be corrected. We concluded that inter-rater reliability and accuracy might be improved if standardized interpretation guidelines were written and used by all reviewers study-wide.
Development of Interpretation Guidelines
UDS Interpretation Guidelines were developed for use during local and central review of UDS tracings. ICS definitions and Good Urodynamic Practice Guidelines were referenced for all
areas in which they were available, however the UDS WG created specific guidelines and definitions for controversial issues for which no guidance could be found in the current literature. Prior to implementation, the Interpretation Guidelines were reviewed and critiqued by an outside consultant and final refinements were approved by the SC. The UDS Interpretation Guidelines provide specific suggestions for validity and plausibility determination, expected ranges of urodynamic variables, reasonable agreement of measuring systems that were to be used by all UITN investigators in order to minimize the individual variation previously identified in our studies. Literature review and a review of the first 200 UITN baseline studies determined expected ranges for baseline pressure measures and queries were sent back to UDS reviewers whenever baseline values fell out of expected value ranges. At both local and central review, the UDS signal was not to be interpreted until the reviewer evaluated the UDS tracing to confirm that it met plausibility criteria. Plausibility rules addressed tracing legibility, protocol adherence and assessment of pressure measurements.
The UDS Interpretation Guidelines can be found at http://www.uitn.net/resourcesforphysicians.htm. Once these guidelines were in place, we performed interrater reliability studies between central and local reviewers for both the CMG and PFS portions of the study. The results of these studies are reported separately.
Comment
Multicenter urodynamic studies require a continuous, committed quality improvement process to ensure that the studies are properly performed and consistently interpreted. Future multicenter urodynamic studies may benefit from the lessons learned by this group and it is for this reason that we have made specific recommendations, based on our experience during this process. In addition we have provided the documents developed for the UITN protocol (the Urodynamic Testing Procedures and the UDS Interpretation Guidelines) at http://www.uitn.net/resourcesforphysicians.htm in the event that other investigators might find them useful when establishing UDS protocols in future studies.
The International Continence Society and its subcommittees have worked diligently to improve the standards and comparability of worldwide UDS 2,7,9,10 . Such work has been invaluable in providing a framework for our work. In spite of these efforts to standardize UDS, obtaining quality UDS data will not be possible in large multi-site studies by simply asking investigators to follow the Good Urodynamics Practice (GUP) guidelines. A recent survey in the U.K.
revealed that clinicians were not convinced that they needed to change their methods to achieve uniformity 11 . Even when the technical aspects of the studies are performed similarly, there remain differences of opinion on how to evaluate and interpret a study. For example, the urodynamic literature suggests that agreement of the abdominal and intravesical signals should be tested throughout the filling study with frequent 'cough checks', Theoretically, the cough spikes should be identical in each system, but a cough is a very rapid (millisecond) to beginning a study, one should strive for near equivalence in the agreement of the pressure lines. The question is how much agreement is acceptable for a study to be included in a data set. Most UDS studies in the literature do not comment on whether the tracings were subjected to plausibility testing. We want to emphasize that some threshold of signal agreement needs to be determined for plausibility interpretation by urodynamic reviewers.
The goal of the UDS WG was to insure that UDS studies were being conducted as described in the protocol and that the data was being interpreted consistently across sites. If UDS are being interpreted by more than one reviewer, then a quality control process should demonstrate that the results are similar when they are reviewed by any competent and qualified interpreter. Interpretation Guidelines are necessary since the literature demonstrates that UDS interpretations are not reliable even with the simplest of urodynamic studies. For example, flow pattern interpretation during free uroflowmetry 13 14 has been shown to be have subsequently performed inter-rater reliability studies to determine the reliability among central reviewers and also between central and local reviewers for free uroflowmetry, filling cystometry, and PFS using the UITN Guidelines. The outcomes of these studies will be reported separately, but they demonstrated improvement over results in our preliminary review.
We were able to markedly improve the technical quality of the urodynamics and our ability to centrally review tracings by standardizing the equipment and creating an electronic central repository. We do not think this is a prerequisite for high quality UDS data, but certainly it is helpful for any central review quality control process.
We recognize the limitations of this report describing a quality control process for managing UDS data in a multicenter study on the surgical treatment of SUI. First of all, this is not an attempt to define how UDS should be performed, nor is it an attempt to define UDS parameters. Rather this is an assessment of the difficulties encountered in implementing the GUP in a multicenter study. UDS are performed nearly universally by clinicians, UDS parameters are frequently cited in the literature. Thus we feel our experience is generalizable to the majority of UDS currently being conducted. We acknowledge that many of the suggestions are not evidence based, but rather the result of consensus and compromise in a multicenter study. Other investigators have centralized the process of UDS interpretation with UDS experts reviewing all UDS tracings. We purposely chose not to have all UDS reviewed by a central expert reviewer because this would not be generalizable to how UDS are being conducted in the community. It is recognized that a different set of investigators with alternative clinical priorities might require a different protocol for the urodynamic procedures;
however the urodynamic procedures that can be found on the website may serve as a starting point for urodynamic procedure design in multicenter studies of women with stress urinary incontinence.
Conclusions
This manuscript details our experience in the development and implementatation of a standardized UDS protocol in a multi-center trial for surgical treatment of stress urinary incontinence. Based on this experience with a two year continuous quality control process, we suggest the following specific strategies for investigators embarking on multicenter urodynamic studies:
8. Develop a system to distribute these electronic signals to distant central reviewers for quality control purposes.
9. Review the signals regularly and provide feedback to testers on how to improve their performance.
10. Develop specific urodynamic interpretation guidelines to maximize interpretation reliability.
